Skip to main content

Change in PDL Status for the Antiemetic-Antivertigo Agents Drug Class Effective January 15, 2025

Last updated on

On January 15, 2025, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from the generic scopolamine patch products on the HHSC preferred drug list (PDL). This change is in response to the distribution delays for patch products with the preferred brand name Transderm Scop.

The non-preferred status has been removed from the following drugs:

National Drug Code (NDC)Drug Name
00378647044Scopolamine 1 mg/3-day patch
00378647097Scopolamine 1 mg/3-day patch
00378647099Scopolamine 1 mg/3-day patch
00591225804Scopolamine 1 mg/3-day patch
00591225823Scopolamine 1 mg/3-day patch
00591225879Scopolamine 1 mg/3-day patch
45802058046Scopolamine 1 mg/3-day patch
45802058062Scopolamine 1 mg/3-day patch
45802058084Scopolamine 1 mg/3-day patch
50742050504Scopolamine 1 mg/3-day patch
50742050510Scopolamine 1 mg/3-day patch
50742050524Scopolamine 1 mg/3-day patch

These changes allow providers to prescribe the generic scopolamine patch products without requiring PDL prior authorization.

Email vdp-formulary@hhsc.state.tx.us with any questions.